----item----
version: 1
id: {DBF01FD7-73AD-49EA-AD5B-B238BC4C1B20}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/05/22/ASCO 2015 Preconference review
parent: {F5E96EB9-60E0-4AAE-863A-DF3CFDF656A2}
name: ASCO 2015 Preconference review
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: a2ea93c9-2ce6-4622-b359-970164347174

----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 35

 ASCO 2015: Pre-conference review  
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 30

ASCO 2015 Preconference review
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1765

<p> In this roundtable <i>The Pink Sheet&rsquo;s</i> Mary Jo Laffler talks to experts from Datamonitor Healthcare, Citeline and BioMedTracker about their top picks from this year's ASCO abstracts, as well as other news to watch out for at the 2015 conference at the end of this month. </p> <p> They discuss highlights in the area of immune-oncology, specifically new combination drug candidates; game-changing data expected for myeloma therapies; how companies are looking at new approaches for old targets in oncology; and more. </p> <p> <preform><iframe src="https://player.vimeo.com/video/128381974" frameborder="0" webkitallowfullscreen="" mozallowfullscreen="" allowfullscreen=""></iframe> <p>ASCO 2015 Pre-Conference Review from <a href="https://vimeo.com/datamonitorhealthcare">Datamonitor Healthcare</a> on <a href="https://vimeo.com">Vimeo</a>.</p></preform></p> <p> <b>Related stories: </b> </p> <p> <a href="http://www.scripintelligence.com/home/Big-pharmas-immunotherapy-game-at-ASCO-358431" target="_new">Big pharma's immunotherapy game at ASCO</a> </p> <p> <a href="http://www.scripintelligence.com/home/Good-Bad-Ugly-the-ASCO-abstracts-are-out-358413" target="_new">Good, Bad, Ugly: the ASCO abstracts are out</a> </p> <p> <p> <b>For more coverage on ASCO 2015: </b> </p> <p> <a href="http://www.scripintelligence.com" target="_new">www.scripintelligence.com</a> </p> <p> <a href="http://www.biomedtracker.com" target="_new">www.biomedtracker.com</a> </p> <p> <a href="http://www.datamonitorhealthcare.com" target="_new">www.datamonitorhealthcare.com</a> </p> <p> <a href="http://www.citeline.com" target="_new">www.citeline.com</a> </p> <p> <a href="https://www.pharmamedtechbi.com/publications/the-pink-sheet" target="_new">The Pink Sheet</a> </p> 
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 289

<p> In this roundtable <i>The Pink Sheet&rsquo;s</i> Mary Jo Laffler talks to experts from Datamonitor Healthcare, Citeline and BioMedTracker about their top picks from this year's ASCO abstracts, as well as other news to watch out for at the 2015 conference at the end of this month. </p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 30

ASCO 2015 Preconference review
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150522T120000
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150522T120000
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150522T120000
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC028802
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 35

 ASCO 2015: Pre-conference review  
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{090E9A04-9B4B-4986-8BAF-06A6B07B978D}
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

358469
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042350Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

a2ea93c9-2ce6-4622-b359-970164347174
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042350Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
